<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940323-1-00072</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4702 -->  <!-- PJG ITAG l=80 g=1 f=1 --> &sect;806.20  <!-- PJG /ITAG -->  <!-- PJG ITAG l=89 g=1 f=1 --> Records of corrections and removals not required to be reported.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> (a) Each device manufacturer or distributor who undertakes a correction or removal of a device that is not required to be reported to FDA under &sect;806.10 shall keep a record of such correction or removal.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (b) Records of corrections and removals not required to be reported to FDA under &sect;806.10 shall contain the following information:  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (1) The brand name, common or usual name, classification name and product code if known, and the intended use of the device.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (2) The model, catalog, or code number of the device and the manufacturing lot or serial number of the device or other identification number.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (3) A complete description of the event giving rise to the information reported and the corrective or removal action that has been, and is expected to be taken.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (4) Justification for not reporting the correction or removal action to FDA shall contain conclusions, any followups, and be reviewed and evaluated by a designated person.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (5) A copy of all communications regarding the correction or removal.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (c) The manufacturer or distributor shall retain all records required to be retained under this section for a period of 2 years beyond the expected life of the device, even if the manufacturer or distributor has ceased to manufacture, import, or distribute the device. Records required to be maintained under paragraph (c) of this section must be transferred to the new owner of the device and maintained for the required period of time.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=80 g=1 f=1 --> &sect;806.30  <!-- PJG /ITAG -->  <!-- PJG ITAG l=89 g=1 f=1 --> FDA access to records.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Each device manufacturer or distributor required under this part to maintain records concerning corrections or removals and every person who is in charge or custody of such records shall, upon request of an officer or employee designated by FDA and pursuant to section 704(e) of the act, permit such officer or employee at all reasonable times to have access to, and to copy and verify, such records and reports.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=80 g=1 f=1 --> &sect;806.40  <!-- PJG /ITAG -->  <!-- PJG ITAG l=89 g=1 f=1 --> Public availability of reports.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> (a) Any report submitted under this part is available for public disclosure in accordance with part 20 of this chapter.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (b) Before public disclosure of a report, FDA will delete from the report:  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (1) Any information that constitutes trade secret or confidential commercial or financial information under &sect;20.61 of this chapter; and  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (2) Any personnel, medical, and similar information, including the serial numbers of implanted devices, which would constitute a clearly unwarranted invasion of personal privacy under &sect;20.63 of this chapter; provided, that except for the information under &sect;20.61 of this chapter, FDA will disclose to a patient who requests a report all of the information in the report concerning that patient.  <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=21 g=1 f=1 --> Dated: March 17, 1994.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <SIGNER> <!-- PJG ITAG l=06 g=1 f=1 --> Michael R. Taylor,  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNER> <SIGNJOB> <!-- PJG ITAG l=04 g=1 f=1 --> Deputy Commissioner for Policy.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNJOB> <FRFILING> <!-- PJG ITAG l=40 g=1 f=1 --> [FR Doc. 94&hyph;6691 Filed 3&hyph;22&hyph;94; 8:45 am] <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </FRFILING> <BILLING> <!-- PJG ITAG l=68 g=1 f=1 --> BILLING CODE 4160&hyph;01&hyph;P <!-- PJG /ITAG --> </BILLING>  <!-- PJG /STAG --></p>
		</main>
</body></html>
            